Case 1. Biotech company Biolidics received a from Singapore Exchange (SGX) about certain noises it was making. Between 30 March and 6 April 2020, Biolidics publicised its solution to Covid—its rapid test kit, and how it was approved for use in , the and the . The well-timed announcements caused its share price to rise…

To access this post, you must purchase Monthly Recurring, Quarterly Subscription or 3-Year Subscription.

AUTHOR

Benjamin Cher

Based in Singapore, Ben covers news and stories from the hub of Southeast Asia. He covers the intersection of technology and business, and how it affects Singapore and Southeast Asia. Ben was previously a reporter at The Edge Singapore.

View Full Profile

Sign up to our Southeast Asia edition to read this story instantly

To sign up, you’ll create an account that will give you access to a new free story published once a week and archive of previously published free stories from our Southeast Asia edition. You’ll also receive one email every morning from us introducing the day’s story.

If you’ve already signed up, just enter your email below or login using Facebook or Google.